SWEDISH ORPHAN BIOVITRUM

Corporation with Board of Directors
Stockholm, Sweden
Closing date: December 31
Date of the Last Annual General Meeting: May 4 2021
- STOXX®Europe 600
- E&B Pharmaceuticals & Biotechnology

Governance leadership structure

Board of Directors

Håkan BJÖRKLUND
Chair
Since about 6 years

Other directorships

10 voting members and 2 non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 4.9 years
5.4 years for elected by shareholders

Directors
average age 57.2 years
57.8 years for elected by shareholders

Chair and CEO roles are separated:
Majority of independent members in the Audit Committee?	No

12 members

Executive Committee

Guido OELKERS
Chief Executive Officer
Since about 5 years
Other directorships

39.5 % Percentage of variable remunerations in 2020 Global compensation

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.